George Grofik | SVP & Head, IR & Communications |
Pablo Legorreta | Founder & CEO |
Jim Reddoch | EVP, Co-Head Research & Investments & CSO |
Marshall Urist | EVP & Co-Head, Research & Investments |
Terry Coyne | EVP & CFO |
Chris Hite | Vice Chairman |
Chris Schott | J.P. Morgan |
Bill Maughan | Bank of America |
Steve Scala | Cowen |
Terence Flynn | Goldman Sachs |
Umer Raffat | Evercore ISI |
Andrew Baum | Citi |
Greg Fraser | Truist Securities |
Ivan Feinseth | Tigress Financial |
Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma Second Quarter 2021 Earnings Conference Call. I would now like to turn the call over to George Grofik, SVP, Head of Investor Relations and Communications. Please go ahead, sir.
Good morning and good afternoon to everyone on the call.